State of Alaska Department of Revenue Acquires 370 Shares of Doximity, Inc. (NASDAQ:DOCS)

State of Alaska Department of Revenue raised its holdings in Doximity, Inc. (NASDAQ:DOCSFree Report) by 2.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,610 shares of the company’s stock after buying an additional 370 shares during the period. State of Alaska Department of Revenue’s holdings in Doximity were worth $780,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in DOCS. UMB Bank n.a. boosted its holdings in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after acquiring an additional 235 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Doximity by 20.6% during the fourth quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock valued at $93,000 after purchasing an additional 296 shares in the last quarter. MetLife Investment Management LLC boosted its holdings in Doximity by 0.6% during the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock worth $2,835,000 after purchasing an additional 363 shares during the last quarter. First Horizon Advisors Inc. grew its position in Doximity by 22.5% in the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after purchasing an additional 384 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its stake in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on DOCS. Barclays boosted their target price on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research note on Monday, November 11th. JPMorgan Chase & Co. upped their price objective on Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research note on Thursday, November 21st. Mizuho lifted their target price on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Stephens initiated coverage on shares of Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 price target for the company. Finally, KeyCorp lowered their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 8th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Doximity currently has a consensus rating of “Moderate Buy” and an average price target of $64.22.

Check Out Our Latest Stock Analysis on DOCS

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 37.40% of the company’s stock.

Doximity Stock Performance

Shares of NASDAQ DOCS opened at $77.13 on Friday. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The stock has a market cap of $14.40 billion, a PE ratio of 77.13, a price-to-earnings-growth ratio of 4.61 and a beta of 1.39. The stock has a fifty day moving average of $57.89 and a 200-day moving average of $47.37.

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.